Literature DB >> 17355876

Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.

Marzena Maćkowiak1, Agnieszka Chocyk, Katarzyna Markowicz-Kula, Krzysztof Wedzony.   

Abstract

Recent evidence indicates that the polysialylated neural cell adhesion molecule (PSA-NCAM) is involved in hippocampal plasticity. On the other hand, CB1 receptor activation is known to disturb some hippocampal processes involving plastic changes, such as learning and memory. Therefore, the present study investigated the effect of HU-210, a CB1 receptor agonist, on the expression of PSA-NCAM protein in the dentate gyrus (DG) and CA3 region of the rat hippocampus. It was found that at a dose of 0.1 mg/kg i.p. of HU-210, the number of PSA-NCAM immunoreactive (IR) cells in the DG declined in a time-dependent manner. The decrease in PSA-NCAM expression was observed at 1 and 2 days (ca. 21% and 30%, respectively), but not after 4 h and 4 days following HU-210 administration. However, HU-210 treatment did not change the length density of PSA-NCAM immunopositive processes in CA3 mossy fibers at all the time points measured. The effect observed in the DG on day 2 was blocked by AM-251 (1 mg/kg, i.p.), a CB1 receptor antagonist, given 30 min before HU-210. Neither the number of Ki-67 (IR) cells (a marker of proliferation) nor the number of doublecortin-IR cells (a marker of immature neurons) was affected by HU-210 (0.1 mg/kg, i.p.) treatment at any of the time points. An analysis of co-localization of CB1 receptor protein with PSA-NCAM protein revealed that both proteins were not present in the same population of neurons in the subgranular layer of the DG. The observed changes in PSA-NCAM expression were not related to the reduction of proliferation or differentiation of newly born cells, but were possible due to alternations in the synaptic activity in the DG. However, such alteration in the PSA-NCAM expression may change the timing of the functional maturation of newly born neurons. Moreover, the above finding suggests that acute activation of CB1 receptors may result in the stiffening of the hippocampal structure and susceptibility to plastic changes and may lead to functional impairment governed by alterations in the hippocampal structure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355876     DOI: 10.1016/j.brainres.2007.02.014

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Effects of addictive drugs on adult neural stem/progenitor cells.

Authors:  Chi Xu; Horace H Loh; Ping-Yee Law
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

Review 2.  Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders.

Authors:  R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

3.  Effect of methamphetamine exposure during pregnancy and lactation on polysialic acid-neural cell adhesion molecule expression in rat's offspring hippocampus.

Authors:  Fariba Baei; Aliakbar Rajabzadeh; Javad Bagheri; Zahra Jalayeri; Alireza Ebrahimzadeh-Bideskan
Journal:  Metab Brain Dis       Date:  2017-02-27       Impact factor: 3.584

Review 4.  The role of cannabinoids in adult neurogenesis.

Authors:  Jack A Prenderville; Áine M Kelly; Eric J Downer
Journal:  Br J Pharmacol       Date:  2015-06-16       Impact factor: 8.739

5.  Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.

Authors:  Susanne A Wolf; Anika Bick-Sander; Klaus Fabel; Perla Leal-Galicia; Svantje Tauber; Gerardo Ramirez-Rodriguez; Anke Müller; Andre Melnik; Tim P Waltinger; Oliver Ullrich; Gerd Kempermann
Journal:  Cell Commun Signal       Date:  2010-06-17       Impact factor: 5.712

6.  Long-Term Stress and Concomitant Marijuana Smoke Exposure Affect Physiology, Behavior and Adult Hippocampal Neurogenesis.

Authors:  Kitti Rusznák; Kata Csekő; Zsófia Varga; Dávid Csabai; Ágnes Bóna; Mátyás Mayer; Zsolt Kozma; Zsuzsanna Helyes; Boldizsár Czéh
Journal:  Front Pharmacol       Date:  2018-07-23       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.